Instil Bio (TIL) Treasury Shares (2020)
Instil Bio (TIL) posted Treasury Shares of $70.2 million for Q4 2020, up 17.74% on a QoQ basis from $59.6 million in Q3 2020.
Analysis
Instil Bio (TIL) Treasury Shares (2020) Analysis & Trends
Instil Bio has reported Treasury Shares for 1 years, with the latest figure at $70.2 million in Q4 2020.
- On a quarterly basis, Treasury Shares changed N/A year-over-year to $70.2 million in Q4 2020; TTM through Dec 2020 was $70.2 million, a N/A change from a year earlier, with the FY2020 full-year figure at $70.2 million, changed N/A from the prior year.
- Treasury Shares was $70.2 million for Q4 2020 at Instil Bio, up from $59.6 million in the prior quarter.
- The five-year high for Treasury Shares was $70.2 million in Q4 2020, with the low at $15.0 million in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 36.40 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -23.80 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Instil Bio | 50.19 Mn | 50.19 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 70.18 Mn |
| Dec 31, 2020 | 70.18 Mn |
| Sep 30, 2020 | 59.60 Mn |
| Sep 30, 2020 | 59.60 Mn |
| Jun 30, 2020 | 59.60 Mn |
| Jun 30, 2020 | 59.60 Mn |
| Mar 31, 2020 | 15.00 Mn |
| Mar 31, 2020 | 15.00 Mn |